Xinqiao Hospital Of Chongqing
Clinical trials sponsored by Xinqiao Hospital Of Chongqing, explained in plain language.
-
New stroke drug could boost recovery when given hours after symptoms start
Disease control Recruiting nowThis study tests whether giving a clot-busting drug (rhTNK-tPA) before a procedure to remove a clot can improve recovery in stroke patients. About 820 adults who had a stroke 4.5 to 24 hours earlier will receive either the drug or a placebo. The goal is to see if the drug helps r…
Phase: PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
MRNA technology takes on blood cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new mRNA-based drug that targets a protein called CD19 on cancer cells. It is for adults with B-cell blood cancers (like lymphoma or leukemia) who have not responded to standard treatments. The drug is delivered via lipid nanoparticles, similar to C…
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Stroke showdown: which Pre-Surgery drug saves more brains?
Disease control Recruiting nowThis study tests which intravenous drug works better before mechanical clot removal in people having a severe stroke caused by a large blocked artery. About 800 adults will receive either tirofiban or alteplase before the procedure. The goal is to see which approach leads to more…
Phase: PHASE2, PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Could a simple CT scan be enough to guide stroke treatment?
Knowledge-focused Recruiting nowThis study looks at whether a simple CT scan can be used to decide if stroke patients need a procedure to remove a blood clot, instead of more complex scans. About 1,846 adults who had a stroke within the last 24 hours will take part. The goal is to see if the simple scan leads t…
Phase: NA • Sponsor: Xinqiao Hospital of Chongqing • Aim: Knowledge-focused
Last updated May 26, 2026 05:10 UTC